IS-217

N/A

Report date: 2023/08/14 09:29:56
NME

Base Information

Drug NameIS-217
Drug Alias NameSoriacareIS-217ISSAR 217
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAnti-Vascular endothelial growth factorInterleukin-17 modulatorsInterleukin-23 modulators
TargetsVascular endothelial growth factorInterleukin-17Interleukin-23
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIssar Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesIssar Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A